Has Herbalife (HLF) Become Undervalued After Its IIT Madras Partnership?
Herbalife (HLF) is back in focus after the company and IIT Madras opened a Center of Excellence for plant cell fermentation technology in Chennai, India, highlighting its push into plant-derived wellness products.
See our latest analysis for Herbalife.
Recent announcements, including the Fuel Like Ronaldo recovery framework and the IIT Madras partnership, come as Herbalife trades at US$13.15, with a 30 day share price return of 16.17% but a 5 year total shareholder return that has declined 74.36%. This suggests that near term momentum contrasts with a much weaker longer term record.
If this kind of wellness themed story has your attention, it could be a good moment to see what else is shaping markets through our screener of 18 top founder-led companies
Herbalife’s rebound and new plant cell fermentation push may tempt you to jump in after the recent move, or to wait for a cheaper entry instead. The next step is to see what the valuation actually says.
Most Popular Narrative: 28.3% Undervalued
At $13.15, Herbalife is trading below a most widely followed fair value estimate of $18.33 per share, which frames how some investors are thinking about the recovery story.
The analysts have a consensus price target of $18.33 for Herbalife based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $25.0, and the most bearish reporting a price target of just $9.0.
Want to see what is behind that valuation gap for Herbalife? The most followed narrative leans on modest revenue growth, improving margins, and a future earnings multiple that assumes disciplined execution. Curious which specific earnings path and discount rate tie it all together?
Result: Fair Value of $18.33 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Herbalife still faces pressure from global regulatory scrutiny of multi level marketing models and persistent skepticism about processed supplements, which could challenge those valuation assumptions.
Find out about the key risks to this Herbalife narrative.
Next Steps
With Herbalife caught between fresh optimism and ongoing questions about its model, this is a moment to act quickly and test the numbers for yourself, starting with 3 key rewards and 3 important warning signs.
Looking for more investment ideas beyond Herbalife?
If Herbalife has sparked your interest, do not stop there. Broaden your watchlist with other focused stock ideas that could fit different roles in your portfolio.
- Target stability first and build a core around companies highlighted in our 76 resilient stocks with low risk scores.
- Hunt for mispriced opportunities by scanning our 44 high quality undervalued stocks.
- Spot potential early movers before they hit the spotlight with our screener containing 19 high quality undiscovered gems.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com